Please contact us for assistance at [email protected]
As traditional lifestyle and behavioral interventions often yield variable outcomes, and with rising projections of childhood obesity, pharmacological treatment options like GLP-1 RAs are becoming increasingly relevant
The cagrilintide and semaglutide dosing chart often follows this schedule: Weeks 1-4 start with 0.25mg semaglutide + 0.6mg cagrilintide weekly, Weeks 5-8 increase to 0.5mg semaglutide + 1.2mg cagrilintide, Weeks 9-12 use 1.0mg semaglutide + 1.2mg cagrilintide, Weeks 13-16 escalate to 1.7mg semaglutide + 1.8mg cagrilintide, Weeks 17-20 reach maintenance at 2.4mg each, and Weeks 21+ continue maintenance doses
If you have thyroid disease and are considering starting a GLP-1 receptor agonist for weight management, a careful, stepwise approach can help ensure the best outcomes and minimize risks
Frequently asked questions "In many cases, no," explains Sanan
GLP-1 medications can be an effective tool for weight loss, but success depends on how well you nourish your body